Authorization and Sale of Securities. The Company is proposing to sell $1,560,000 aggregate principal amount of the Securities to the Investors.
Appears in 1 contract
Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.)
Authorization and Sale of Securities. The Company is proposing to sell $1,560,000 67,145 aggregate principal amount of the Securities to the Investors.
Appears in 1 contract
Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.)
Authorization and Sale of Securities. The Company is proposing to sell $1,560,000 65,000,000 aggregate principal amount of the Securities to the InvestorsSecurities.
Appears in 1 contract
Samples: Securities Purchase Agreement (Pernix Therapeutics Holdings, Inc.)
Authorization and Sale of Securities. The Company is proposing to sell $1,560,000 2,238,166.45 aggregate principal amount of the Securities to the Investors.
Appears in 1 contract
Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.)
Authorization and Sale of Securities. The Company is proposing to sell up to $1,560,000 65,000,000 aggregate principal amount of the Securities, including the Securities sold directly to the Investors.
Appears in 1 contract
Samples: Securities Purchase Agreement (Bacterin International Holdings, Inc.)
